MIMS Full Prescribing Update
New / Revised |
Product Name |
Section changed |
---|---|---|
New | Actikerall | |
New | Adenosine Baxter | |
New | ARX-Sunitinib | |
New | Bepanthen Scar Treatment | |
New | Berocca Boost | |
New | Cabazitaxel Accord | |
New | Cholfen Eye Drops | |
New | Curium Gallium (Ga-67) Citrate (Curium Netherlands B.V.) | |
New | Curium Gallium (Ga-67) Citrate (UK) | |
New | Elevit Probiotics Immunity & Gut Health | |
New | Fyton | |
New | Hydroxycarbamide Medicianz | |
New | Idarubicin Hydrochloride Injection, USP (West-ward/ Hikma) | |
New | Illuccix | |
New | Inqovi 35/100 | |
New | Ketorolac Medsurge | |
New | Metabolics Potassium Citrate 10 | |
New | Noumed Bisoprolol | |
New | Noumed Celecoxib | |
New | Nurofen Meltlets Berry Burst | |
New | Oxybutynin Hydrochloride Tablets (Niche Generics Limited) | |
New | Paracetamol/Codeine GH 500/15 | |
New | Pharmacy Action Cetrelief (Unscheduled) | |
New | Sitagliptin Sun | |
New | Spikevax Bivalent Original/Omicron | |
New | TechneLite Generator | |
New | Tnkase (Canada) (Medsurge Healthcare) | |
New | Tnkase (Canada) (Pro Pharmaceuticals Group) | |
New | Vancomycin Viatris | |
New | Voriconazole-AFT | |
New | Zanzole 24HR | |
Revised | Accupril | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Actemra | Adverse Effects (Undesirable Effects), Special Precautions for Storage |
Revised | Actilyse | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Adenocor | Adverse Effects (Undesirable Effects) |
Revised | Adenoscan | Adverse Effects (Undesirable Effects) |
Revised | Aethoxysklerol | TGA Date |
Revised | Alepam | Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Ambrisentan Viatris | List of Excipients, Nature and Contents of Container, Product Name change |
Revised | Amgevita | Adverse Effects (Undesirable Effects) |
Revised | Amisulpride Sandoz Pharma | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Anapen | Dose and Method of Administration, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | APO-Aripiprazole | Adverse Effects (Undesirable Effects) |
Revised | APO-Ciprofloxacin | Adverse Effects (Undesirable Effects) |
Revised | APO-Lamotrigine | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APO-Lorazepam | TGA Date |
Revised | APO-Lurasidone | TGA Date |
Revised | APO-Sertraline | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | APO-Telmisartan HCTZ | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | APO-Temozolomide | Fertility, Pregnancy and Lactation |
Revised | APO-Ursodeoxycholic Acid | TGA Date |
Revised | APX-Ondansetron | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | APX-Ondansetron ODT | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Overdose, Special Warnings and Precautions for Use |
Revised | Aripiprazole Generichealth | Adverse Effects (Undesirable Effects) |
Revised | Atrovent Metered Aerosol (CFC-free) | Special Warnings and Precautions for Use |
Revised | Avapro | Adverse Effects (Undesirable Effects) |
Revised | Avapro HCT | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Azacitidine Accord | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | B. Braun 0.9% Sodium Chloride Injection | Pharmaceutical Form, Physicochemical Properties, Special Precautions for Storage |
Revised | B. Braun 0.9% Sodium Chloride Intravenous Infusion BP | List of Excipients, Physicochemical Properties, Product Name change, Shelf Life |
Revised | B. Braun 5% Glucose Intravenous Infusion BP | List of Excipients, Physicochemical Properties, Product Name change, Shelf Life |
Revised | B. Braun Compound Sodium Lactate Intravenous Infusion BP | List of Excipients, Physicochemical Properties, Product Name change, Shelf Life |
Revised | Bactrim | Pharmaceutical Form |
Revised | Baxter Metronidazole | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use |
Revised | Biodone Forte | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Bisalax | Adverse Effects, Contraindications, Description, Dosage and Administration, Indications, Interactions with Other Medicines, Pharmacology, Precautions, Presentation, Storage |
Revised | Blincyto | TGA Date |
Revised | Breztri Aerosphere | Dose and Method of Administration, Nature and Contents of Container |
Revised | Cabenuva | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Calindamin | Adverse Effects (Undesirable Effects), List of Excipients, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Capecitabine-DRLA | Special Warnings and Precautions for Use |
Revised | Caprelsa | Deleted Presentation, Dose and Method of Administration, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Carbaglu | TGA Date |
Revised | Ceclor | List of Excipients, Nature and Contents of Container |
Revised | Ceftriaxone Viatris | Nature and Contents of Container, Product Name change, Special Precautions for Storage |
Revised | Cipla Imatinib Adult | Adverse Effects (Undesirable Effects), Pharmacological Properties |
Revised | Ciprofloxacin GH | Adverse Effects (Undesirable Effects) |
Revised | Clarithro | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Clopidogrel Sandoz Pharma | Interactions with Other Medicines and Other Forms of Interactions |
Revised | Clustran | TGA Date |
Revised | Combivir | Special Warnings and Precautions for Use |
Revised | Comirnaty | Dose and Method of Administration, Shelf Life, Special Precautions for Storage |
Revised | Contrave 8/90 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Cosentyx | Adverse Effects (Undesirable Effects) |
Revised | Cosmegen | TGA Date |
Revised | Coumadin | Nature and Contents of Container |
Revised | Coveram | Overdose |
Revised | Crestor | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container |
Revised | Cyramza | Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Dalacin C Injection | Dose and Method of Administration, Nature and Contents of Container, Pharmacological Properties |
Revised | DBL Carboplatin Injection | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | DBL Sulfamethoxazole 400 mg and Trimethoprim 80 mg Concentrate Injection BP | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Desvenlafaxine GH XR | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Special Warnings and Precautions for Use |
Revised | Dexmedetomidine Mylan | Dose and Method of Administration, Nature and Contents of Container, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Diflucan | Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Dilantin | Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Enstilar | Adverse Effects (Undesirable Effects), Pharmaceutical Form |
Revised | Entecavir RBX | Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Epilim | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Epilim IV | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Erlotinib Apotex | TGA Date |
Revised | Eskazole | List of Excipients, Nature and Contents of Container |
Revised | Esomeprazole Sandoz Hp7 | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use |
Revised | Estraderm MX | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Ezovir | Nature and Contents of Container, Special Precautions for Storage |
Revised | Ferriprox | TGA Date |
Revised | Fluorouracil Ebewe | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Folotyn | TGA Date |
Revised | Forxiga | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Fostair | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use |
Revised | Heparinised Saline Injection (Pfizer) | Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Hexvix | Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Pharmaceutical Form, Pharmacological Properties, Physicochemical Properties, Qualitative and Quantitative Composition, Shelf Life, Sponsor |
Revised | Hydroxycarbamide Medsurge | Dose and Method of Administration, Fertility, Pregnancy and Lactation |
Revised | Idacio | Adverse Effects (Undesirable Effects) |
Revised | Ikervis | Special Warnings and Precautions for Use |
Revised | Jakavi | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Kalma | Nature and Contents of Container |
Revised | Karvea | Adverse Effects (Undesirable Effects) |
Revised | Karvezide | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Keytruda | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties,Therapeutic Indications |
Revised | Kinson | List of Excipients, Nature and Contents of Container, Pharmaceutical Form |
Revised | Labetalol SXP | TGA Date |
Revised | Lacosamide Lupin | Fertility, Pregnancy and Lactation |
Revised | Lamivudine/Zidovudine Viatris 150/300 | Nature and Contents of Container, Product Name change, Special Precautions for Storage |
Revised | Leustatin | Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Lincomycin SXP | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Linevox | Special Warnings and Precautions for Use |
Revised | Madeline | Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Meropenem Juno | Adverse Effects (Undesirable Effects) |
Revised | Metaraminol Juno | Special Precautions for Storage |
Revised | Mifepristone Linepharma | Adverse Effects (Undesirable Effects), New contraindication, Special Warnings and Precautions for Use |
Revised | Monurol | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Moxicam Capsules | Sponsor,TGA Date |
Revised | MS-2 Step | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, New contraindication, Special Warnings and Precautions for Use |
Revised | Neupogen | TGA Date |
Revised | Noradrenaline BNM | Contraindications |
Revised | Noralin | Contraindications |
Revised | Noumed Amlodipine | TGA Date |
Revised | Noumed Mirtazapine | Dose and Method of Administration, List of Excipients |
Revised | Ofev | Pharmacological Properties |
Revised | Olmesartan HCT-MYL | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Olmesartan/ Amlodipine - MYL | Adverse Effects (Undesirable Effects) |
Revised | Olmesartan-MYL | Adverse Effects (Undesirable Effects) |
Revised | Olmetec | Adverse Effects (Undesirable Effects) |
Revised | Olmetec Plus | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ondansetron Alphapharm | Adverse Effects (Undesirable Effects), Nature and Contents of Container, Special Warnings and Precautions for Use |
Revised | Ondansetron APOTEX | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Oseltamivir Lupin | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties |
Revised | Ostelin Specialist Range Vitamin D 7000IU | Therapeutic Indications |
Revised | Oxaliplatin Accord | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, Special Warnings and Precautions for Use |
Revised | Oxycodone Juno | Pharmacological Properties |
Revised | Oxyndone | Sponsor |
Revised | Paracetamol BNM | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Pedea | TGA Date |
Revised | Pfizer (Australia) Carboplatin | Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Pharmacor Teriflunomide | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Phebra Calcium Chloride Dihydrate 10% Injection | Nature and Contents of Container, Product Name change, Qualitative and Quantitative Composition |
Revised | Phebra Potassium Chloride 22.3% Concentrated Injection | Pharmaceutical Form, Product Name change |
Revised | Piax | Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Plidogrel | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Polivy | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmaceutical Form |
Revised | Qarziba | Adverse Effects (Undesirable Effects), Pharmaceutical Form, Pharmacological Properties |
Revised | Qinlock | Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions |
Revised | RBX Topiramate | Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Physicochemical Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use |
Revised | Reaptan | Overdose |
Revised | Renitec Plus 20/6 | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Ristempa | TGA Date |
Revised | Rixadone | Nature and Contents of Container |
Revised | Rocuronium Bromide Medsurge | Adverse Effects (Undesirable Effects) |
Revised | Rythmodan | Sponsor |
Revised | Saxenda | Adverse Effects (Undesirable Effects), Dose and Method of Administration |
Revised | Sertra | Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Physicochemical Properties, Special Warnings and Precautions for Use |
Revised | Setrona | Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Sevikar | Adverse Effects (Undesirable Effects) |
Revised | Sevikar HCT | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Shingrix | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions |
Revised | Signifor | TGA Date |
Revised | Signifor LAR | TGA Date |
Revised | Sodium Valproate Juno | Pharmacological Properties |
Revised | Sodium Valproate Sandoz | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Somac Heartburn Relief | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Somac Tablets and Granules | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Spikevax | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Stilnox | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Talminex | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties |
Revised | Tamosin | Nature and Contents of Container, Pharmaceutical Form, Sponsor |
Revised | Tarceva | Pharmacological Properties |
Revised | Targin | TGA Date |
Revised | Tecentriq | Adverse Effects (Undesirable Effects) |
Revised | Teltartan HCT | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use |
Revised | Tenofovir Disoproxil Emtricitabine Viatris 300/200 | Nature and Contents of Container, Product Name change |
Revised | Terrosa | Adverse Effects (Undesirable Effects), Contraindications, Fertility, Pregnancy and Lactation, New contraindication, Shelf Life, Special Warnings and Precautions for Use |
Revised | Tofranil | List of Excipients, Pharmaceutical Form |
Revised | Toradol | List of Excipients, Pharmaceutical Form |
Revised | Trelegy Ellipta | Adverse Effects (Undesirable Effects) |
Revised | Trexject | Special Warnings and Precautions for Use |
Revised | Trizivir | Special Warnings and Precautions for Use |
Revised | Trodelvy | Dose and Method of Administration, Shelf Life |
Revised | Ultomiris 100 mg/mL | Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Uptravi | Adverse Effects (Undesirable Effects), Dose and Method of Administration |
Revised | Valpro EC | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Valproate Winthrop | Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Vasafil | Pharmaceutical Form |
Revised | Vaxzevria | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Vectibix | TGA Date |
Revised | Vecure | Nature and Contents of Container, Pharmaceutical Form, Qualitative and Quantitative Composition |
Revised | Victoza | Adverse Effects (Undesirable Effects), Dose and Method of Administration |
Revised | Vocabria | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use |
Revised | Voriconazole Sandoz | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Vttack | Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Xospata | Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties |
Revised | Zamic | Contraindications, Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use |
Revised | Zarontin | Adverse Effects (Undesirable Effects) |
Revised | Zepzelca | Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use |
Revised | Zotren | Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use |
Revised | Zotren ODT | Adverse Effects (Undesirable Effects), Overdose, Special Warnings and Precautions for Use |
Revised | Zydol | Special Precautions for Storage |
Deleted | APO-Tramadol/Paracetamol | |
Deleted | Aspen Fentanyl | |
Deleted | Bupivacaine-Baxter | |
Deleted | Clopidogrel APOTEX | |
Deleted | Daivobet 50/500 Gel | |
Deleted | Eurofolic (Germany) | |
Deleted | Integrilin | |
Deleted | Joncia | |
Deleted | Ketorolac-Baxter | |
Deleted | Meropenem APOTEX | |
Deleted | Metronide | |
Deleted | Nopil | |
Deleted | Parapane Osteo | |
Deleted | Phentermine Juno ER | |
Deleted | Pramipexole XR GP | |
Deleted | Trandate |
Copyright © MIMS Australia Pty Ltd. All rights reserved.
MIMS Australia
Suite 1602, Level 16
44 Market Street
Sydney NSW 2000
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au